Neprilysins regulate muscle contraction and heart function via cleavage of SERCA-inhibitory micropeptides.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35906206.
- Also identified by DOI 10.1038/s41467-022-31974-1 and PMC identifier 9338278.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Muscle contraction depends on strictly controlled Ca<sup>2+</sup> transients within myocytes. A major player maintaining these transients is the sarcoplasmic/endoplasmic reticulum Ca<sup>2+</sup> ATPase, SERCA. Activity of SERCA is regulated by binding of micropeptides and impaired expression or function of these peptides results in cardiomyopathy. To date, it is not known how homeostasis or turnover of the micropeptides is regulated. Herein, we find that the Drosophila endopeptidase Neprilysin 4 hydrolyzes SERCA-inhibitory Sarcolamban peptides in membranes of the sarcoplasmic reticulum, thereby ensuring proper regulation of SERCA. Cleavage is necessary and sufficient to maintain homeostasis and function of the micropeptides. Analyses on human Neprilysin, sarcolipin, and ventricular cardiomyocytes indicates that the regulatory mechanism is evolutionarily conserved. By identifying a neprilysin as essential regulator of SERCA activity and Ca<sup>2+</sup> homeostasis in cardiomyocytes, these data contribute to a more comprehensive understanding of the complex mechanisms that control muscle contraction and heart function in health and disease.
Medical subject headings
- Calcium-Binding Proteins
- Neprilysin